|
|||
|
Multiple Sclerosis Info
Search
This Month
|
Tuesday, May 6
Atacicept Phase 2 Clinical Trial In Relapsing Multiple Sclerosis
by
multiplesclerosis
on Tue 06 May 2008 08:16 AM CST
ZymoGenetics, Inc. (NASDAQ:ZGEN), announced that its development partner Merck Serono, a division of Merck KGaA, Darmstadt, Germany, has initiated a Phase 2 clinical trial to more »
|
||
